EMG
CDLX icon

Ellington Management Group’s Cardlytics CDLX Stock Holding History

Ellington Management Group’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-780
Closed -$261K – 539
2019
Q3 		$261K Buy
+780
New +$250K 0.05% 420

Other funds holding CDLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Ellington Management Group's CDLX Position: Q4 2019 in Review

Ellington Management Group sold out of Cardlytics (CDLX) in Q4 2019, closing a stake of 780 shares — an estimated $261K sold.

Ellington Management Group first reported a position in CDLX in Q3 2019 and held it in 1 quarter. The position peaked at $261K in Q3 2019. 156 funds tracked by Wall St. Rank hold CDLX as of Q4 2019.

  • Ellington Management Group reported no remaining Cardlytics position as of Q4 2019 after selling out during the quarter.
  • Ellington Management Group sold 780 Cardlytics shares in Q4 2019, an estimated $261K.
  • Ellington Management Group first reported a position in Cardlytics in Q3 2019 and held it in 1 quarter.
  • Ellington Management Group's Cardlytics position peaked at $261K in Q3 2019.
  • 156 funds tracked by Wall St. Rank held Cardlytics as of Q4 2019.

Based on Ellington Management Group's 13F filing for Q4 2019, filed 14 Feb 2020.